{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:08:58Z","timestamp":1761512938146},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T00:00:00Z","timestamp":1374364800000},"content-version":"vor","delay-in-days":3003,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.curtheres.2005.06.004","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:26:36Z","timestamp":1298107596000},"page":"230-237","source":"Crossref","is-referenced-by-count":5,"title":["Effects of lamotrigine monotherapy in patients with newly diagnosed juvenile myoclonic epilepsy: An open-label study"],"prefix":"10.1016","volume":"66","author":[{"given":"James R.","family":"Schimschock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Kustra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Messenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.curtheres.2005.06.004_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1989.tb05832.x","article-title":"Juvenile myoclonic epilepsy: Characteristics of a primary generalized epilepsy","volume":"30","author":"Dreifuss","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2005.06.004_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneur.1993.00540060034013","article-title":"Juvenile myoclonic epilepsy: A review","volume":"50","author":"Gr\u00fcnewald","year":"1993","journal-title":"Arch Neurol."},{"key":"10.1016\/j.curtheres.2005.06.004_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1528-1157.1994.tb02432.x","article-title":"Juvenile myoclonic epilepsy: A 5-year prospective study","volume":"35","author":"Panayiotopoulos","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2005.06.004_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1059-1311(05)80097-4","article-title":"Characterization of intractable juvenile myoclonic epilepsy: New perspectives on primarily generalized seizures","volume":"2","author":"Dasheiff","year":"1993","journal-title":"Seizure"},{"key":"10.1016\/j.curtheres.2005.06.004_bib5","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1006\/ebeh.2001.0283","article-title":"The Expert Consensus Guideline Series: Treatment of epilepsy","volume":"2","author":"Karceski","year":"2001","journal-title":"Epilepsy Behau"},{"key":"10.1016\/j.curtheres.2005.06.004_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-8749.1977.tb08015.x","article-title":"Treatment of generalised epilepsies of childhood with sodium valproate","volume":"19","author":"Jeavons","year":"1977","journal-title":"Dev Med Child Neurol."},{"key":"10.1016\/j.curtheres.2005.06.004_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.34.3.285","article-title":"Juvenile myoclonic epilepsy of Janz","volume":"34","author":"Delgado-Escueta","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.curtheres.2005.06.004_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1059-1311(96)80110-5","article-title":"The use of lamotrigine in juvenile myoclonic epilepsy","volume":"5","author":"Buchanan","year":"1996","journal-title":"Seizure"},{"issue":"Suppl 2","key":"10.1016\/j.curtheres.2005.06.004_bib9","first-page":"160","article-title":"Efficacy of lamotrigine as monotherapy in juvenile myoclonic epilepsy: Pilot study results","volume":"34","author":"Timmings","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2005.06.004_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2005.06.004_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5694\/j.1326-5377.1995.tb138476.x","article-title":"Juvenile myoclonic epilepsy: Diagnosis, management and outcome","volume":"162","author":"Sharpe","year":"1995","journal-title":"Med J Aust."},{"key":"10.1016\/j.curtheres.2005.06.004_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0920-1211(95)00085-2","article-title":"A randomized open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrentepilepsy","volume":"23","author":"Reunanen","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.curtheres.2005.06.004_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","article-title":"An active-control trial of lamotrigine monotherapy for partial seizures","volume":"51","author":"Gilliam","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.curtheres.2005.06.004_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1684\/j.1950-6945.1999.tb00315.x","article-title":"Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: A video-EEG-controlled, open study","volume":"1","author":"Gericke","year":"1999","journal-title":"Epileptic Disord."},{"issue":"Suppl 5","key":"10.1016\/j.curtheres.2005.06.004_bib15","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1528-1157.1999.tb00917.x","article-title":"Lamotrigine","volume":"40","author":"Matsuo","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2005.06.004_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1528-1157.1999.tb05562.x","article-title":"Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin","volume":"40","author":"Steiner","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2005.06.004_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isoj\u00e4rvi","year":"1996","journal-title":"Ann Neurol."},{"key":"10.1016\/j.curtheres.2005.06.004_bib18","first-page":"52","article-title":"Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy","volume":"21","author":"Murialdo","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.curtheres.2005.06.004_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.curtheres.2005.06.004_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2005.06.004_bib21","series-title":"The Treatment of Epilepsy: Principles and Practice","first-page":"484","article-title":"Juvenile myoclonic epilepsy","author":"Delgado-Escueta","year":"1997"},{"key":"10.1016\/j.curtheres.2005.06.004_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yebeh.2004.04.002","article-title":"Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: Results of an open-label study","volume":"5","author":"Morris","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.curtheres.2005.06.004_bib23","series-title":"Lamictal (lamotrigine) tablets","year":"2004"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T09:12:38Z","timestamp":1712221958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X05000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0011393X05000573"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2005.06.004","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}